Both IgG and IgM anti-beta2 glycoprotein I antibodies assays are clinically useful to the antiphospholipid syndrome diagnosis

References

• Hughes GR. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clin Res Ed). 1983;287(6399):1088–9.
   PubMed Web of Science ®Google Scholar
• Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum. 1999;42(7):1309–11.
   PubMed Web of Science ®Google Scholar
• McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci. 1990;87(11):4120–4.
   Web of Science ®Google Scholar
• Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJ, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet. 1990;335(8705):1544–7.
   PubMed Web of Science ®Google Scholar
• Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet.1990;336(8708):177–8.
   Google Scholar
• Pierangeli SS, Chen PP, Raschi E, Scurati S, Grossi C, Borghi MO, et al. Antiphospholipid antibodies and the antiphospholipid syndrome: pathogenic mechanisms. Semin Thromb Hemost. 2008;34(3):236–50.
   Web of Science ®Google Scholar
• Wong RC, Favaloro EJ. Clinical features, diagnosis, and management of the antiphospholipid syndrome. Semin Thromb Hemost. 2008;34(3):295–304.
   Web of Science ®Google Scholar
• Giannakopoulos B, Passam F, Ioannou Y, Krilis SA. How we diagnose the antiphospholipid syndrome? Blood. 2009;113:985–94.
   PubMed Web of Science ®Google Scholar
• Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol. 2011;7(6):330–9.
   Web of Science ®Google Scholar
• Girardi G, Redecha P, Salmon JE. Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation. Nat Med. 2004;10:1222–6.
   PubMed Web of Science ®Google Scholar
• Girardi G. Heparin treatment in pregnancy loss: Potential therapeutic benefits beyond anticoagulation. J Reprod Immun. 2005;66(1):45–51.
   Web of Science ®Google Scholar
• Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.
   PubMed Web of Science ®Google Scholar
• Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2009;7(10):1737–40.
   PubMed Web of Science ®Google Scholar
• Pierangeli SS, de Groot PG, Dlott J, Favaloro E, Harris EN, Lakos G, et al. ‘Criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies. Lupus. 2011;20(2):182–90.
   Web of Science ®Google Scholar
• Devreese KM. Antiphospholipid antibody testing and standardization. Int J Lab Hematol. 2014;36(3):352–63.
   Web of Science ®Google Scholar
• Keeling D, Mackie I, Moore GW, Greer IA, Greaves M. British Committee for Standards in Haematology. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2012;157(1):47–58.
   Web of Science ®Google Scholar
• Roubey RA. Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice. Lupus. 2010;19(4):440–5.
   Web of Science ®Google Scholar
• Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood. 2003;101(5):1827–32.
   Web of Science ®Google Scholar
• Galli M, Luciani D, Bertolini G, Barbui T. Anti-beta 2-glycoprotein I, Antiprothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood. 2003;102(8):2717–23.
   Web of Science ®Google Scholar
• Pengo V. APS–controversies in diagnosis and management, critical overview of current guidelines. Thromb Res. 2011;127(Suppl 3):S51–2.
   Web of Science ®Google Scholar
• Ruffatti A, Tonello M, Del Ross T, Cavazzana A, Grava C, Noventa F, et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost. 2006;96:337–41.
   PubMed Web of Science ®Google Scholar
• Bao SH, Wang XP, Lin QD, Di W, Xu L, Ding CW. The investigation on the value of repeat and combination test of ACA and anti-beta2-GPI antibody in women with recurrent spontaneous abortion. Am J Reprod Immunol. 2008;60(4):372–8.
   Web of Science ®Google Scholar
• Hvas AM, Ingerslev J, Salvig JD. Thrombophilia risk factors are associated with intrauterine foetal death and pregnancy-related venous thromboembolism. Scand J Clin Lab Invest. 2009;69(2):288–94.
   Web of Science ®Google Scholar
• Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. N Engl J Med. 2001;345(19):1400–8.
   Web of Science ®Google Scholar
• Zammiti W, Mtiraoui N, Kallel C, Mercier E, Almawi WY, Mahjoub T. A case-control study on the association of idiopathic recurrent pregnancy loss with autoantibodies against beta2-glycoprotein I and annexin V. Reproduction. 2006;131(4):817–22.
   Web of Science ®Google Scholar
• Meroni PL, Gerosa M, Raschi E, Scurati S, Grossi C, Borghi MO. Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss. Clin Rev Allergy Immunol. 2008;34(3):332–7.
   Web of Science ®Google Scholar
• Boffa MC, Boinot C, De Carolis S, Rovere-Querini P, Aurousseau MH, Allegri F, et al. Laboratory criteria of the obstetrical antiphospholipid syndrome. Data from a multicentric prospective European women cohort. Thromb Haemost. 2009;102(1):25–8.
   Web of Science ®Google Scholar
• Chauleur C, Galanaud JP, Alonso S, Cochery-Nouvellon E, Balducchi JP, Marès P, et al. Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies. J Thromb Haemost. 2010;8(4):699–706.
   Web of Science ®Google Scholar
• Alijotas-Reig J, Ferrer-Oliveras R, Rodrigo-Anoro MJ, Farran-Codina I, Cabero-Roura L, Vilardell-Tarres M. Anti-beta(2)-glycoprotein-I and anti-phosphatidylserine antibodies in women with spontaneous pregnancy loss. Fertil Steril. 2010;93(7):2330–6.
   Web of Science ®Google Scholar